Literature DB >> 27599243

Cardiovascular disease in COPD: time to quash a silent killer.

Charlotte E Bolton1, Jennifer K Quint2, Mark T Dransfield3.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27599243     DOI： 10.1016/S2213-2600(16)30243-0

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  4 in total

1.  COPD is a clear risk factor for increased use of resources and adverse outcomes in patients undergoing intervention for colorectal cancer: a nationwide study in Spain.

Authors:  Marisa Baré; Concepción Montón; Laura Mora; Maximino Redondo; Marina Pont; Antonio Escobar; Cristina Sarasqueta; Nerea Fernández de Larrea; Eduardo Briones; Jose Maria Quintana
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-21

2.  Standard expected years of life lost (SEYLL) due to chronic obstructive pulmonary disease (COPD) in Poland from 1999 to 2014.

Authors:  Elzbieta Dziankowska-Zaborszczyk; Marek Bryla; Beata Ciabiada-Bryla; Irena Maniecka-Bryla
Journal:  PLoS One       Date:  2019-03-12       Impact factor: 3.240

3.  Building toolkits for COPD exacerbations: lessons from the past and present.

Authors:  Elizabeth Sapey; Mona Bafadhel; Charlotte Emma Bolton; Thomas Wilkinson; John R Hurst; Jennifer K Quint
Journal:  Thorax       Date:  2019-07-03       Impact factor: 9.139

4.  Premature Mortality Due to Chronic Obstructive Pulmonary Disease (COPD) in Poland.

Authors:  Waclaw Moryson; Barbara Stawinska-Witoszynska
Journal:  Medicina (Kaunas)       Date:  2021-02-01       Impact factor: 2.430
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.